|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
41,630,000 |
Market
Cap: |
26.95(M) |
Last
Volume: |
204,752 |
Avg
Vol: |
421,671 |
52
Week Range: |
$0.6474 - $0.6474 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
166,159 |
Total Buy Value |
$0 |
$0 |
$0 |
$81,668 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bedrosian Arthur P |
CEO |
|
2017-06-30 |
4 |
A |
$17.34 |
$8,115 |
D/D |
468 |
689,361 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2017-06-30 |
4 |
A |
$17.34 |
$7,526 |
D/D |
434 |
23,472 |
|
- |
|
Galvan Martin P |
VP of Finance & CFO |
|
2017-04-24 |
4 |
D |
$24.30 |
$7,970 |
D/D |
(328) |
40,723 |
|
- |
|
Landis G. Michael |
Principal Accounting Officer |
|
2017-04-24 |
4 |
D |
$24.30 |
$437 |
D/D |
(18) |
4,764 |
|
- |
|
Smith Kevin |
VP of Sales and Marketing |
|
2017-04-24 |
4 |
D |
$24.30 |
$7,946 |
D/D |
(327) |
19,301 |
|
- |
|
Bedrosian Arthur P |
CEO |
|
2017-04-24 |
4 |
D |
$24.30 |
$16,111 |
D/D |
(663) |
688,893 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2017-03-31 |
4 |
A |
$19.00 |
$6,460 |
D/D |
340 |
23,038 |
|
- |
|
Abt John |
Vice President of Quality |
|
2017-03-31 |
4 |
A |
$19.00 |
$4,522 |
D/D |
238 |
8,734 |
|
- |
|
Landis G. Michael |
Principal Accounting Officer |
|
2017-03-31 |
4 |
A |
$19.00 |
$4,446 |
D/D |
234 |
4,782 |
|
- |
|
Smith Kevin |
VP of Sales and Marketing |
|
2017-03-31 |
4 |
A |
$19.00 |
$8,531 |
D/D |
449 |
19,628 |
|
- |
|
Bedrosian Arthur P |
CEO |
|
2017-03-31 |
4 |
A |
$19.00 |
$12,293 |
D/D |
647 |
689,556 |
|
- |
|
Abt John |
Vice President of Quality |
|
2017-03-30 |
4 |
D |
$22.50 |
$6,638 |
D/D |
(295) |
8,496 |
|
- |
|
Bedrosian Arthur P |
CEO |
|
2017-02-06 |
4 |
B |
$20.00 |
$200,000 |
D/D |
10,000 |
688,909 |
2.81 |
- |
|
Landis G. Michael |
Principal Accounting Officer |
|
2016-12-31 |
4 |
A |
$18.74 |
$5,172 |
D/D |
276 |
4,548 |
|
- |
|
Farber David |
10% Owner |
|
2016-12-13 |
4 |
AS |
$25.00 |
$5,000 |
D/D |
(200) |
1,930,870 |
|
- |
|
Farber David |
10% Owner |
|
2016-12-09 |
4 |
AS |
$25.30 |
$151,800 |
D/D |
(6,000) |
1,931,070 |
|
- |
|
Farber David |
10% Owner |
|
2016-12-02 |
4 |
AS |
$25.00 |
$95,000 |
D/D |
(3,800) |
1,937,070 |
|
- |
|
Landis G. Michael |
Principal Accounting Officer |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
4,272 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,681 |
22,542 |
|
- |
|
Galvan Martin P |
VP of Finance & CFO |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,681 |
41,051 |
|
- |
|
Smith Kevin |
VP of Sales and Marketing |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,681 |
19,179 |
|
- |
|
Abt John |
Vice President of Quality |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,681 |
8,791 |
|
- |
|
Bedrosian Arthur P |
CEO |
|
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,351 |
678,909 |
|
- |
|
Farber Jeffrey |
Director |
|
2016-11-07 |
4 |
OE |
$6.89 |
$34,450 |
D/D |
5,000 |
2,438,826 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2016-09-30 |
4 |
A |
$21.20 |
$3,307 |
D/D |
156 |
22,698 |
|
- |
|
762 Records found
|
|
Page 13 of 31 |
|
|